Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene

Human Immunology

Volumn 60, Issue 12, 1999, Pages 1245-1249

  Brogan, Iain J ^a   Khan, Naeem ^a   Isaac, Kevin ^a   Hutchinson, James A ^a   Pravica, Vera ^a   Hutchinson, Ian V ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5' UTR; Gene polymorphism; Promoter; VEGF

Indexed keywords

DNA; HLA ANTIGEN; VASCULOTROPIN;

5' UNTRANSLATED REGION; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE INSERTION; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSLATION INITIATION;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; GENE FREQUENCY; GENOTYPE; HUMANS; LYMPHOKINES; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033400238     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00132-9     Document Type: Article

References (20)

1. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Res. 13:1992;18.
2. Senger D.R., Van De Water L., Brown L.F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metasi Rev. 12:1993;303.
3. Berse B., Brown L.F., Van De Water L., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 3:1992;211.
4. Iijima K., Yoshikawa N., Connolly D.T., Nakamura H. Human mesangial cells produce vascular permeability factor. Kidney Int. 42:1992;1457.
5. Freeman M.R., Schneck F.X., Gagnon M.L. Peripheral blood lymphocytes infiltrating human cancers express vascular endothelial growth factor a potential role for T cells in angiogenesis . Cancer Res. 55:1995;4140.
6. Vincenti V., Cassano C., Rocchi M., Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 93:1996;1493.
7. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 266:1991;11947.
8. Klagsbrun M., D'Amore P. Vascular endothelial growth factor and its receptors. Cyt Growth Factor Rev. 7:1996;259.
9. Minchenko A., Salceda S., Bauer T., Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res. 40:1994;35.
10. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor expression in endothelial cells identification of a 5′ enhancer . Circ Res. 77:1995;638.
11. Hutchinson I.V., Pravica V., Sinnott P.J. Genetic regulation of cytokine synthesis consequences for acute and chronic organ allograft rejection . Graft. 1:1998;186.
12. Perrey C., Pravica V., Sinnott P.J., Hutchinson I.V. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes a technical report . Trans Immunol. 6:1998;193.
13. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms in human DNA by gel electrophoresis as single-stranded conformational polymorphisms. Proc Natl Acad Sci USA. 86:1989;2766.
14. Stein I., Itin A., Einat P., Skaliter R., Grossman Z., Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry implications for translation under hypoxia . Mol Cell Biol. 18:1998;3112.
15. Akiri G., Nahari D., Finkelstein Y., Le S.-Y., Elroy-Stein O., Levi B.-Z. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene. 17:1998;227.
16. Carmeliet P., Ferriera V., Brier G. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435.
17. Awad M.R., El-Gamel A., Simm E., Hasleton P.S., Yonan N., Deiraniya A.K., Sinnott P.J., Hutchinson I.V. Genotypic variation in the transforming growth factor beta 1 gene association with TGF-β1 production, fibrotic lung disease and graft fibrosis after lung transplantation . Transplantation. 67:1998;1014.
18. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., Hutchinson I.V. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogenet. 26:1999;1.
19. Wilson A., Symons J., McDowell T., McDevitt H., Duff G. Effects of a polymorphism in the human tumour necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA. 49:1997;3195.
20. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 24:1997;1.